Meet
Vivian Ting

Research Scientist II

Vivian Ting uses her knowledge of healthcare analytics to tailor data-driven solutions for clients.

In recent projects, Vivian has analyzed claims data to help life sciences manufacturers characterize patients, providers, and utilization patterns to support coding and access strategies as well as model the financial impact of increased drug uptake within CMS care models.   

Before joining Avalere, Vivian was a senior data analyst at a health insurance provider, where she used healthcare claims to provide analytic insights to stakeholders. Her work informed key decision-making processes within the company and among commercial employer groups.

Vivian holds an MA in economics and education from Teachers College, Columbia University, and a BS in economics from the University of Tulsa.

Authored Content


Medicare payment and Part B drug pricing changes may increase financial pressure on certain independent physician practices, varying by specialty and site of care.

An Avalere Health analysis determined that less than 1% of patients with community-acquired bacterial pneumonia were treated with novel antibiotics.

With IRA, MFN, and OBBBA pressures, manufacturers must assess coverage shifts, demographics, and payer mix to refine channel strategy and improve patient access.